JNJ

Johnson & Johnson

$254.66

9.78 (3.99%) Today

— up— down

Market Cap

$613.02B+67.1%

Revenue (TTM)

$94.87B+7.9%

Net Income (TTM)

$20.81B-3.9%

EPS (TTM)

8.65-3.9%

Shares Out

2.41B

2.41B

P/E Ratio

29.14

29.14

Forward P/E

19.80

19.80

Dividend

$5.14 (2.19%)

$5.14 (2.19%)

Ex-Dividend Date

May 26, 2026

May 26, 2026

Open

$254.66

$254.66

Previous Close

$244.88

$244.88

Day Range

$247.87 – $255.08

$247.87 – $255.08

52-Week Range

$151.52 – $255.11

$151.52 – $255.11

Beta

0.20

0.20

Volume

16.24M

16.24M

Avg Volume

8.15M

8.15M

Analyst Rating

Buy

Buy

Exchange

NEW YORK STOCK EXCHANGE, INC.

NEW YORK STOCK EXCHANGE, INC.

About JNJ

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey.

Related

News

Johnson & Johnson (JNJ) – Among the 10 Best Dividend Stocks to Buy for Passive Income

Yahoo · 6h ago

Johnson & Johnson (JNJ) Unveils IMAAVY Data That Could Expand Early gMG Use

Yahoo · 1d ago

Why Johnson & Johnson Stock Popped on Friday

Yahoo · 1d ago

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

Yahoo · 1d ago

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Yahoo · 1d ago